Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Revenue (2023 - 2025)

Historic Revenue for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $1.7 million.

  • CG Oncology's Revenue rose 377441.86% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 21783.63%. This contributed to the annual value of $1.1 million for FY2024, which is 45833.33% up from last year.
  • As of Q3 2025, CG Oncology's Revenue stood at $1.7 million, which was up 377441.86% from $52000.0 recorded in Q1 2025.
  • CG Oncology's 5-year Revenue high stood at $1.7 million for Q3 2025, and its period low was $1000.0 during Q4 2023.
  • Over the past 3 years, CG Oncology's median Revenue value was $111000.0 (recorded in 2024), while the average stood at $340111.1.
  • As far as peak fluctuations go, CG Oncology's Revenue soared by 4550000.0% in 2024, and later plummeted by 9017.01% in 2025.
  • Quarter analysis of 3 years shows CG Oncology's Revenue stood at $1000.0 in 2023, then skyrocketed by 45500.0% to $456000.0 in 2024, then soared by 265.35% to $1.7 million in 2025.
  • Its Revenue was $1.7 million in Q3 2025, compared to $52000.0 in Q1 2025 and $456000.0 in Q4 2024.